General Information of Drug (ID: DMCSLZ4)

Drug Name
Sodium zirconium cyclosilicate Drug Info
Synonyms UZSi 9; ZS-9 compound; Sodium zirconium silicate (Na2ZrSi3O9); UZSi-9; CBTCHTJSGLCFMY-UHFFFAOYSA-N; 543686-27-7
Indication
Disease Entry ICD 11 Status REF
Hyperkalemia 5C76 Approved [1]
Cross-matching ID
PubChem CID
91799284
CAS Number
CAS 17141-74-1
TTD Drug ID
DMCSLZ4

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Drug(s) Targeting Potassium (K)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Patiromer calcium DMMIQ20 Hyperkalemia 5C76 Approved [2]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Potassium (K) TTB0SC6 NOUNIPROTAC Binder [1]

References

1 2018 FDA drug approvals.Nat Rev Drug Discov. 2019 Feb;18(2):85-89.
2 Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial. Eur Heart J. 2011 Apr;32(7):820-8.